Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study With Genotype - Phenotype Correlation
NCT02498340 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2015-07-15
Summary
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is prevalent and add a burden on families in Egypt and Middle East due to lifelong diet restriction, non-fava beans diet is main food for most families in the region and parents and doctors consider it as a prohibited food whatever the genetic or clinical phenotypes. The effective management is avoiding a spectrum of food and drugs causing oxidative stress. No data is available about the hazards of consumption of non-fava beans diet.
Conditions
- Glucose-6-Phosphate Dehydrogenase Deficiency
Interventions
- DIETARY_SUPPLEMENT
-
non- fava beans
Patients will be subjected to eat non- fava beans diet at doses of 10 -30 gm (small to moderate amount) of 3 different types of non- fava beans, each one will be given once daily for 3 days.
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2016-07-31
Countries
- Egypt
Study Locations
More Related Trials
-
Steroids in Fulminant Hepatitis A in the Pediatric Age Group
NCT02375867 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Metreleptin in Congenital Leptin Deficiency
NCT04063488 ·Status: COMPLETED
-
Fibrates in Pediatric Cholestasis
NCT03586674 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis
NCT01934777 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study Evaluating Efficacy, Safety and Molecular Mechanism of N-acetylcysteine Supplementation in Patients With Hepatic and Post Hepatic Jaundice
NCT06236165 ·Status: COMPLETED ·Phase: PHASE2
-
Elastography in Liver Cell Failure
NCT06089785 ·Status: NOT_YET_RECRUITING
-
Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects
NCT01002261 ·Status: COMPLETED
-
Hepatoprotective Measures for Children at High Risk of NAFLD
NCT06918080 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency
NCT04147936 ·Status: COMPLETED ·Phase: NA
-
Comparison of Atherogenic Risk Factors and Efficacy of Nutritional Treatment Among Adult Phenylketonuria Patients
NCT04969809 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Vitamin E Supplementation in Hyperinsulinism/Hyperammonemia Syndrome
NCT03797222 ·Status: COMPLETED ·Phase: NA
-
DHA and Vitamin D in Children With Biopsy-proven NAFLD
NCT02098317 ·Status: COMPLETED ·Phase: PHASE3
-
Regulation of FGF21 by Nutritional Challenges
NCT00968747 ·Status: COMPLETED ·Phase: NA
-
Role of Fenofibrate in Indirect Neonatal Hyperbilirubinemia: a Randomized Control Trial
NCT04868019 ·Status: UNKNOWN ·Phase: NA
-
Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia
NCT06517862 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
NCT00465751 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy
NCT03100513 ·Status: UNKNOWN ·Phase: PHASE4
-
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668 ·Status: COMPLETED ·Phase: NA
-
Effects of Amino Acid Supplementation on Liver Lipid Content and Protein Metabolism in Obese Children
NCT02337894 ·Status: WITHDRAWN ·Phase: NA
-
A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group
NCT00986895 ·Status: COMPLETED ·Phase: PHASE1
-
Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease
NCT01553500 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Vitamin A and Calcium in Patients With Non-alcoholic Fatty Liver Disease
NCT06031532 ·Status: COMPLETED
-
Aromatic Amino Acid Metabolism in the Pathogenesis of Kwashiorkor
NCT00429351 ·Status: COMPLETED
-
Impact of Chlordecone on Active Chronic Hepatitis
NCT03373396 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of N-acetyl Cysteine, Acetyl L- Carnitine and Medicated Paraffin Oil in Aluminium Phosphide Poisoning
NCT04509258 ·Status: UNKNOWN ·Phase: PHASE4